[7-9-2015] The U.S. Food and Drug Administration (FDA) is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can increase the chance of a heart attack or stroke, which can lead to death.
Continue reading FDA article here…
I am a highly motivated honours graduate with over 12 years’ experience working within the regulated Pharmaceutical industry for the major Blue Chip companies. Specialising in GMP / Quality Compliance with focus on qualification as well as Change Investigation / Management to support Continuous Process Improvement.